Conformis Struggles with Supply for New Products

Conformis reported 2Q22 orthopedic sales of $15.3 million, -72.9% compared to 2Q21. A one-time royalty payment last year drove the decline. Product revenue for 2Q22 declined -0.4% vs the prior year.

The full launch of the company's Imprint Knee got pushed into the late third quarter because of key component shortages. While currently in...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0